Company Analysis

Barinthus Biotherapeutics plc (BRNS)

BRNS · Pharmaceutical Preparations · Germantown, MD · filing with the SEC since 2020
Grade4.5
◀ Past 4.8● Present 5.1▶ Future 3.7
4 est.

Filings

157 filings since 2017 beside 117 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026
Due next and emerging growth company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 37 days after the quarter ended. The proxy statement was last filed Jun 10, 2026.

Filings a yearinsider forms included
1695244383040
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Sep 9, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Apr 22, 2026.
Insider forms 117

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Sep 21, 2026 15-12G Deregistration notice
Sep 14, 2026 EFFECT Registration effective
Sep 11, 2026 SCHEDULE 13G/A Large holder update, amended
Sep 9, 2026 25 Delisting notice
Sep 9, 2026 S-8 POS Employee stock plan update
Sep 9, 2026 S-8 POS Employee stock plan update
Sep 9, 2026 S-8 POS Employee stock plan update
Sep 9, 2026 S-8 POS Employee stock plan update
Sep 9, 2026 S-8 POS Employee stock plan update
Sep 9, 2026 POS AM Registration amended after taking effect
Sep 1, 2026 8-K items 3.01, 8.01 Listing warning from its exchange; Other event · Current report
Aug 25, 2026 8-K items 3.01, 7.01, 8.01, 9.01 Listing warning from its exchange; Investor disclosure (Regulation FD); Other event · Current report Aug 24, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Jul 2, 2026 8-K items 5.07, 8.01 Shareholder vote; Other event · Current report Jun 30, 2026
Jun 10, 2026 ARS Annual report to shareholders Dec 31, 2025
Jun 10, 2026 DEF 14A Proxy statement Jul 2, 2026
May 21, 2026 8-K item 5.07 Shareholder vote · Current report May 20, 2026
Apr 30, 2026 10-Q Quarterly report Mar 31, 2026
Apr 30, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 DEFM14A Merger proxy statement
Apr 22, 2026 8-K item 5.02 Officer or director change · Current report
Apr 13, 2026 SCHEDULE 13D Activist holder notice
Mar 31, 2026 8-K item 5.02 Officer or director change · Current report Mar 27, 2026
Mar 13, 2026 10-K Annual report Dec 31, 2025
Mar 13, 2026 8-K items 2.02, 7.01 Results released; Investor disclosure (Regulation FD) · Current report
Feb 23, 2026 425 Merger communication
Feb 23, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report
Jan 6, 2026 8-K item 3.01 Listing warning from its exchange · Current report Dec 30, 2025
Dec 10, 2025 8-K item 7.01 Investor disclosure (Regulation FD) · Current report
Nov 7, 2025 10-Q Quarterly report Sep 30, 2025
Nov 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2025 425 Merger communication
Sep 30, 2025 425 Merger communication
Sep 30, 2025 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report Sep 29, 2025
Aug 8, 2025 8-K/A items 2.02, 9.01 Results released · Current report, amended Aug 7, 2025
Aug 7, 2025 10-Q Quarterly report Jun 30, 2025
Aug 7, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 10, 2025 8-K item 5.07 Shareholder vote · Current report
40 of 157 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BRNS · research, not advice